REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Behner S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Behner S.A.S. Profile Updated: December 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Behner SAS is a scientific and commercial support organization. The company offers distribution of input, reactors, and technology for clinical laboratory, as well as comprehensive advice to customers in bacteriology, biomedical, and administrative engineering. Behner SAS also provides up-to-date equipment and medical devices for diagnosing hyperthyroidism and other thyroid diseases.

Headquarters
Parque Industrial Zimura Bodega 23 Kilometro 4 Anillo Anillo Vial Via Giron Floridablanca
Giron; Santander;

Contact Details: Purchase the Behner S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Behner S.A.S. report to view the information.
Registered Capital:
Purchase the Behner S.A.S. report to view the information.
Financial Auditors:
Purchase the Behner S.A.S. report to view the information.
Incorporation Date:
February 04, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Behner S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
14.39%▲
Total operating revenue
14.25%▲
Operating Profit/Loss (EBIT)
-38.81%▼
EBITDA
-38.59%▼
Net Profit/Loss for the Period
10.35%▲
Total Assets
2.35%▲
Total Equity
37.54%▲
Operating Profit Margin (ROS)
-3.39%▼
Net Profit Margin
-0.14%▼
Return on Equity (ROE)
-6.72%▼
Quick Ratio
0.09%▲
Cash Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo